These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 34984135)

  • 21. A study to assess the outcome in COVID-19 confirmed cases receiving Remdesivir as compared to conventional therapy: Medical records-based audit.
    Prabhu D; Kulkarni A; Thyagaraj V; Balaji V; Kumar TA; Rao MY
    J Family Med Prim Care; 2022 Jun; 11(6):3133-3137. PubMed ID: 36119268
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Retrospective Study of Dexamethasone, Remdesivir, and Baricitinib in Severe COVID-19.
    Ngo DQ; Hamid K; Rana H; Cardinale M; Frenia D; Ghani N; Redel H
    Can J Infect Dis Med Microbiol; 2022; 2022():9209618. PubMed ID: 35845297
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical outcomes by supplemental oxygen use in remdesivir-treated, hospitalised adults with COVID-19.
    Arber N; Shah PL; Assoumou L; Rokx C; De Castro N; Bakhai A; Soriano Viladomiu A; Mateu L; Lumbreras C; Estrada V; Curran A; Sellier PO; Duffy A; Fletcher C; Mozaffari E; Haubrich R; Hodgkins P; Pozniak A; Raffi F
    Infect Dis Now; 2023 Oct; 53(7):104760. PubMed ID: 37454762
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and Safety of Remdesivir over Two Waves of the SARS-CoV-2 Pandemic.
    Poliseno M; Gallo C; Cibelli DC; Minafra GA; Bottalico IF; Bruno SR; D'Errico ML; Montemurro L; Rizzo M; Barbera L; Custodero GE; La Marca A; Lo Muzio D; Miucci A; Santantonio TA; Lo Caputo S
    Antibiotics (Basel); 2021 Dec; 10(12):. PubMed ID: 34943688
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Remdesivir administration for Japanese COVID-19 patients undergoing maintenance hemodialysis: a retrospective observation with six case reports.
    Ito J; Kimura M; Toya T; Isozumi K; Kawaji A; Isozaki Y; Fukagawa M
    Ren Replace Ther; 2022; 8(1):14. PubMed ID: 35433033
    [TBL] [Abstract][Full Text] [Related]  

  • 26. COVID-19 Mortality and Remdesivir - A Retrospective Cohort in Intensive Care Setting.
    Xavier ES; Nair VR; Shajahan SP; Raheem A; Philips G; Valsalan P; Pradeep M
    Cureus; 2023 Dec; 15(12):e51002. PubMed ID: 38259359
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Study of Clinical Outcome and Healthcare Modalities of COVID-19 Patients Treated With Remdesivir at a Tertiary Care Teaching Hospital.
    Acharya TA; Joshi KJ; Patel DD; Shah SN; Mehta DS
    Cureus; 2022 Jan; 14(1):e21535. PubMed ID: 35106259
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Convalescent plasma therapy for coronavirus disease 2019 in ambulatory versus hospitalized patients: Efficacy and risk of thromboembolism.
    Li PY; Yu P; Li A; Khalid F; Laureano ML; Crowther MA
    Res Pract Thromb Haemost; 2023 Feb; 7(2):100068. PubMed ID: 36777286
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of safety and outcomes related to remdesivir treatment among dialysis patients hospitalized with COVID-19.
    Zaki KE; Huang CW; Zhou H; Chung J; Selevan DC; Rutkowski MP; Sim JJ
    Clin Kidney J; 2022 Nov; 15(11):2056-2062. PubMed ID: 36320364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Convalescent plasma therapy and remdesivir duo successfully salvaged an early liver transplant recipient with severe COVID-19 pneumonia.
    Jamir I; Lohia P; Pande RK; Setia R; Singhal AK; Chaudhary A
    Ann Hepatobiliary Pancreat Surg; 2020 Nov; 24(4):526-532. PubMed ID: 33234758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Remdesivir Prescription in Pregnant Women Infected with COVID-19: A Report of Compassionate Use.
    Zafarbakhsh A; Vaezi A; Haghjooy Javanmard S; Sabet F; Dehghan M
    Adv Biomed Res; 2023; 12():163. PubMed ID: 37564441
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment effect of remdesivir on the mortality of hospitalised COVID-19 patients in Switzerland across different patient groups: a tree-based model analysis.
    Estill J; Venkova-Marchevska P; Günthard HF; Botero-Mesa S; Thiabaud A; Roelens M; Vancauwenberghe L; Damonti L; Heininger U; Iten A; Schreiber PW; Sommerstein R; Tschudin-Sutter S; Troillet N; Vuichard-Gysin D; Widmer A; Hothorn T; Keiser O
    Swiss Med Wkly; 2023 Aug; 153():40095. PubMed ID: 37769356
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Remdesivir in Severe COVID-19 and Non-Invasive Ventilation: A Real-Life Experience.
    Simioli F; Nicoletta C; Valentino MR; Martino M; Annunziata A; Carannante N; Di Micco P; Fiorentino G
    Healthcare (Basel); 2021 Aug; 9(9):. PubMed ID: 34574882
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association Between COVID-19 Outcomes and Patient Characteristics: A Study in an Inner-City Community Hospital.
    Almonte M; Au XY; Ali M; Rajabalee N; Hasan S; Shibre T; Li Y; Kaplan AC
    Cureus; 2021 Aug; 13(8):e17255. PubMed ID: 34540480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use and Safety of Remdesivir in Kidney Transplant Recipients With COVID-19.
    Buxeda A; Arias-Cabrales C; Pérez-Sáez MJ; Cacho J; Cabello Pelegrin S; Melilli E; Aladrén MJ; Galeano C; Lorenzo I; Mazuecos A; Saura IM; Franco A; Ruiz-Fuentes MDC; Sánchez-Cámara LA; Siverio O; Martin ML; González-García E; López V; Martin-Moreno PL; Moina I; Moral Berrio E; Moreso F; Portolés JM; Santana-Estupiñán R; Zárraga S; Canal C; Sánchez-Álvarez E; Pascual J; Crespo M
    Kidney Int Rep; 2021 Sep; 6(9):2305-2315. PubMed ID: 34250317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapid Response to Remdesivir in Hospitalised COVID-19 Patients: A Propensity Score Weighted Multicentre Cohort Study.
    Leegwater E; Dol L; Benard MR; Roelofsen EE; Delfos NM; van der Feltz M; Mollema FPN; Bosma LBE; Visser LE; Ottens TH; van Burgel ND; Arbous SM; El Bouazzaoui LH; Knevel R; Groenwold RHH; de Boer MGJ; Visser LG; Rosendaal FR; Wilms EB; van Nieuwkoop C
    Infect Dis Ther; 2023 Oct; 12(10):2471-2484. PubMed ID: 37801280
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Effectiveness of the Use of Regdanvimab (CT-P59) in Addition to Remdesivir in Patients with Severe COVID-19: A Single Center Retrospective Study.
    Chae G; Choi A; Lim S; Park S; Lee S; Ahn Y; Kim J; Ra S; Jegal Y; Ahn J; Park E; Jun J; Kwon W; Lee T
    Trop Med Infect Dis; 2022 Mar; 7(3):. PubMed ID: 35324598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcomes Among Patients Hospitalized for COVID-19 Treated with Remdesivir in an Urban Center Pre-COVID-19 Vaccination.
    Chew D; Shiau S; Sudharshan S; Alankar A; Desilva M; Kodali S; Raquepo TM; Meilad N; Sudyn A; Swaminathan S
    J Racial Ethn Health Disparities; 2023 Nov; ():. PubMed ID: 38012432
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early Outpatient Treatment With Remdesivir in Patients at High Risk for Severe COVID-19: A Prospective Cohort Study.
    Rajme-López S; Martinez-Guerra BA; Zalapa-Soto J; Román-Montes CM; Tamez-Torres KM; González-Lara MF; Hernandez-Gilosul T; Kershenobich-Stalnikowitz D; Sifuentes-Osornio J; Ponce-de-León A; Ruíz-Palacios GM
    Open Forum Infect Dis; 2022 Oct; 9(10):ofac502. PubMed ID: 36285176
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of Remdesivir on inflammatory and prognostic markers of COVID-19: Findings of an event-monitoring study.
    Singh S; Sinha N; Lohani P; Agarwal N; Singh P; Singh CM
    J Family Med Prim Care; 2023 Dec; 12(12):3135-3141. PubMed ID: 38361897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.